XML 51 R41.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Summary of Stock Options Awards and Restricted Stock Grants (Details) - USD ($)
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted average exercise price, granted $ 1.18 $ 1.32
Share-Based Payment Arrangement, Option [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Options outstanding, beginning balance 1,063,482  
Weighted average exercise price, beginning balance $ 2.62  
Options outstanding, granted 584,500  
Weighted average exercise price, granted $ 1.18  
Options outstanding, vested and issued  
Weighted average exercise price, vested and issued  
Options outstanding, Terminated (305,512)  
Weighted average exercise price, Terminated $ 1.73  
Options outstanding, ending balance 1,342,470  
Weighted average exercise price, ending balance $ 2.19  
Weighted average contractual terms 8 years 8 months 12 days  
Options outstanding, aggregate intrinsic value  
Options outstanding, exercisable 789,297  
Weighted average exercise price, exercisable $ 2.87  
Weighted average contractual terms, exercisable 8 years 4 months 24 days  
Options outstanding, aggregate intrinsic value, exercisable $ 42,813  
Restricted Stock [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Non-vested stock awards, beginning balance 32,100  
Weighted average grant date fair value, beginning balance $ 1.23  
Non-vested stock awards, granted  
Weighted average grant date fair value, granted  
Non-vested stock awards, vested and issued (2,100)  
Weighted average grant date fair value, vested and issued $ 1.30  
Non-vested stock awards, Terminated  
Weighted average grant date fair value, Terminated  
Non-vested stock awards, ending balance 30,000  
Weighted average grant date fair value, ending balance $ 1.23